Next Generation Sequencing

Cardiac Disease Genetic Testing

By |2020-09-08T10:13:35-05:00July 9th, 2020|Genetic Testing, Heart Disease, Next Generation Sequencing, Precision Medicine|

CARDIAC DISEASE AND GENETIC FACTORS Genes are what make you similar to your relatives. Problems (pathogenic mutations) in genes can cause your family members to be at risk for a [...]

The Role of Genetic Testing in Inherited Cardiovascular Disease

By |2020-09-03T15:42:58-05:00January 20th, 2020|Genetic Testing, Heart Disease, Next Generation Sequencing|

Hereditary Cardiovascular Risk Assessment is the Most Effective Way of Identifying At-Risk Individuals or Confirming a Diagnosis of Existing Cardiac Conditions. It Opens the Door for More Precise and Individualized [...]

Sensitive and Accurate Detection of Circulating Tumor DNA in Plasma

By |2017-02-15T16:38:25-06:00February 15th, 2017|Circulating Tumor DNA, Next Generation Sequencing|

Advanced Solution for Targeted Next Generation Sequencing (NGS) of Circulating Cell-Free Tumor DNA. ctDNA (Circulating Tumor DNA) consist of only a small fraction of cfDNA (Cell Free DNA). ctDNA mutations [...]

Noninvasive Mouthwash Method Of Collecting DNA!

By |2017-05-11T13:49:41-05:00January 26th, 2017|Next Generation Sequencing, Pharmacogenetic Testing, Precision Medicine, Research|

Quantity and Quality of DNA are Similar to Blood Methods! Ayass BioScience, LLC now accepts mouthwash as a collection method for genomic DNA for our Pharmacogenetic Testing. This method is [...]

Liquid Biopsies – High Sensitivity Cancer Detection

By |2020-05-17T17:37:53-05:00January 16th, 2017|Circulating Tumor DNA, Genetic Testing, Next Generation Sequencing, Research|

SCREENING AND EARLY CANCER DETECTION • REAL TIME MONITORING OF CANCER THERAPY Dying cancer cells shed very small amount of DNA into blood. Gene-sequencing machines decode millions of short fragments [...]

Mitochondrial DNA (mtDNA) Mutation and Myopathy

By |2017-01-13T09:07:34-06:00January 10th, 2017|Genetic Testing, mtDNA, Next Generation Sequencing|

The Mitochondrial genome is extremely small when compared to the nuclear genome, and mitochondrial DNA (mtDNA) mutations are complex and difficult to trace, but they play an important role in [...]

CYP Genetic (Genotyping) Testing! Precision Medicine in Toxicology Drug Interactions and Labeling

By |2020-05-17T17:37:53-05:00December 27th, 2016|Next Generation Sequencing, Toxicology|

Cytochrome P450 (CYP450) tests help determine how your body processes (metabolizes) or responds to medications. We look for variations in cytochrome P450 genes that can affect the breakdown of medications. Depending [...]

Mass Spectrometry – Proteomics – Metabolomics – for Disease – Specific Biomarkers

By |2020-05-17T17:37:54-05:00December 22nd, 2016|Genetic Testing, Mass Spectrometry, Next Generation Sequencing, Research|

The Proteomics studies that corroborate Metabolomics findings are the next generation of laboratory testing using the Mass Spectrometry, a key technology for targeted protein and metabolite identification and quantification. This assay [...]

Solid Tumor NGS DNA Testing!

By |2017-01-19T11:29:00-06:00December 16th, 2016|Genetic Testing, Next Generation Sequencing, Solid Tumor|

At Ayass BioScience, we use high-throughput Next Generation Sequencing technology to sequence cancer patients' solid tumor DNA (Breast cancer, Lung cancer, Colorectal cancer, Prostate cancer, Cervical cancer). Targeted sequencing of tumor DNA across our [...]

COVID-19 Testing. COVID-19 Drive-Through Testing Facility. COVID-19 Antibody Testing.

COVID-19 Testing. COVID-19 Drive-Through Testing Facility. COVID-19 Antibody Testing.

Ayass BioScience, LLC

8501 Wade Blvd. Bldg 9, Frisco, TX 750934

Phone: 972-668-6005

Fax: 972-668-6720

Go to Top